Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

114.51
+1.431.26%
Post-market: 114.510.00000.00%16:10 EDT
Volume:289.00K
Turnover:33.10M
Market Cap:1.03B
PE:92.78
High:115.80
Open:115.15
Low:114.21
Close:113.08
52wk High:118.00
52wk Low:85.91
Shares:8.99M
Float Shares:8.99M
Volume Ratio:0.93
T/O Rate:3.22%
Dividend:2.17
Dividend Rate:1.90%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):147.47

Loading ...

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Novo Nordisk Share Price Already Reflects Plenty of Pessimism

Dow Jones
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28

Novartis AG Falls Thursday, Underperforms Market

Dow Jones
·
Aug 28

PPHE Hotel Group ties senior bonuses to equity with new share option grants

TIPRANKS
·
Aug 28

Eli Lilly (LLY) Says Zepbound Cuts Healthcare Costs For Adults Over 55

Simply Wall St.
·
Aug 27

China's HBM Holdings H1 Revenue Rises on Progress on Mid-Late Clinical Stage Programs

Reuters
·
Aug 27

Novo Nordisk Shares Drop as Bank Downgrade Reflects Growth Concerns

Dow Jones
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27

Novo Nordisk says China’s NMPA accepted application for marketing of Wegovy

TIPRANKS
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

Ozempic Maker Novo Nordisk Downgraded to Sell After 70% Stock-Price Dive from Peak

Dow Jones
·
Aug 27

Novo Nordisk (0QIU) was downgraded to a Sell Rating at Deutsche Bank

TIPRANKS
·
Aug 27

Novo Nordisk Faces Growth Concerns Ahead of Important Investor Day

Dow Jones
·
Aug 27

AbbVie Seeks EMA Approval for Skyrizi Subcutaneous Induction in Crohn’s Disease

Reuters
·
Aug 27

Abbvie Submits Regulatory Application to Ema for Skyrizi® (Risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease

THOMSON REUTERS
·
Aug 27

RBC Capital Reaffirms Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Aug 27

Eli Lilly & Co. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Aug 27

AbbVie Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 27

Sector Update: Healthcare

MT Newswires Live
·
Aug 27